Oxford Immunotec Global reported $14.86M in Gross Profit on Sales for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Bruker BRKR:US $ 280.6M 1.9M
Edap Tms EDAP:US $ 4.22M 0.15M
Fluidigm FLDM:US 16.42M 2.62M
Genmark Diagnostics GNMK:US $ 19.4M 2.86M
Hologic HOLX:US $ 701.6M 384.2M
Illumina ILMN:US $ 802M 38M
Laboratory Of America LH:US $ 1264.8M 334.2M
Luminex LMNX:US $ 66.46M 2.02M
Myriad Genetics MYGN:US $ 135.7M 12.9M
Natus Medical BABY:US $ 66.4M 0.09M
Oxford Immunotec Global OXFD:US $ 14.86M 11.19M
Pacific Biosciences Of California PACB:US $ 13.75M 0.78M
Quest Diagnostics DGX:US $ 1111M 114M
Quidel QDEL:US $ 106.19M 195.77M
Sientra SIEN:US 11.26M 1.04M
Thermo Fisher Scientific TMO:US $ 4688M 521M
Trinity Biotech TRIB:US $ 11.03M 0.11M
Veracyte VCYT:US $ 37.63M 13.33M
Waters WAT:US $ 401.39M 47M